Cingulate Inc. Form 8-K Summary
Business Context and Reporting Period
Cingulate Inc. (CING) filed this Current Report on Form 8-K on May 16, 2023. The Company is incorporated in Delaware and its securities trade on the Nasdaq Capital Market. The report addresses a notification received from Nasdaq regarding compliance with continued listing standards.
Key Financial Metrics
The filing discloses specific financial data related to the listing deficiency:
- Stockholders' Equity: $81,614 (as reported in the Form 10-Q for the period ended March 31, 2023).
- Required Minimum Equity: $2.5 million.
- Alternative Compliance Standards Not Met: Market value of listed securities of $35 million or net income from continuing operations of $500,000.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity beyond the stockholders' equity figure.
Material Changes and Listing Status
The Company received a letter from Nasdaq indicating non-compliance with Listing Rule 5550(b)(1) due to insufficient stockholders' equity. As of May 15, 2023, the Company also failed to meet alternative compliance standards regarding market value or net income. There is no immediate impact on the listing; the common stock and warrants will continue to trade on Nasdaq pending the Company's response.
Outlook, Risks, and Management Commentary
The Company intends to submit a plan to regain compliance within 45 calendar days (by June 30, 2023). If accepted, Nasdaq may grant an extension of up to 180 days (until November 12, 2023) to achieve compliance. If the plan is rejected, the Company has the right to appeal to a Nasdaq hearings panel. Management explicitly states there can be no assurance that the plan will be accepted or that the Company will regain or maintain compliance with Nasdaq requirements.
Key Facts for Investor Verification
- Verify the Company's stockholders' equity of $81,614 against the $2.5 million Nasdaq requirement.
- Monitor the submission of the compliance plan by the June 30, 2023 deadline.
- Assess the risk of delisting if the compliance plan is rejected or if the Company fails to meet the extended deadline.
- Review the most recent Form 10-Q for the period ended March 31, 2023, for full financial context.